All In MedTech

Device Trial Radar · NCT00744861

Ultrasound as Adjunct Therapy for Increasing Fusion Success After Lumbar Surgery

EXO-SPINE: A Prospective, Multi-center, Double-blind, Randomized, Placebo Controlled Pivotal Study of Ultrasound as Adjunctive Therapy for Increasing Posterolateral Fusion Success Following Single Level Posterior Instrumented Lumbar Surgery

Last checked: Nov 20, 2026Latest source record: Apr 2, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

TerminatedResults posted on the registryPivotal-lookingTitle says "pivotal". Randomized with 328 participants. This is a heuristic, not a regulatory label.

Status

Terminated

Enrollment

328

Actual

Start

Sep 2008

Primary completion

May 2012

Study completion May 2012

Sponsor

Lead sponsor
Bioventus LLCNot on our public-company list
Sponsor type
Industry
First posted
Sep 1, 2008

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 81 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Adjunct therapy for increasing posterolateral fusion success following single level posterior instrumented lumbar surgery.

Conditions

  • Lumbar Degenerative Disc Disease

Interventions

  • Exospine shamDevice

    Inactive Exospine LIPUS device (dual transducers)

  • ExospineDevice

    Active Exospine LIPUS device (dual transducers)

  • Exogen 4000+Device

    Active Exogen LIPUS device (single transducer)

  • Exogen 4000+ shamDevice

    Inactive Exogen 4000+ LIPUS device (single transducer)

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Participants With Posterolateral Fusion Success at the Treated LevelTime frame: 12 months post treatment start

Locations

No sites are listed on the registry yet.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.